BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33846459)

  • 1. Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
    Perez-Bercoff D; Laude H; Lemaire M; Hunewald O; Thiers V; Vignuzzi M; Blanc H; Poli A; Amoura Z; Caval V; Suspène R; Hafezi F; Mathian A; Vartanian JP; Wain-Hobson S
    Sci Rep; 2021 Apr; 11(1):7893. PubMed ID: 33846459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
    Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
    Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.
    Scholtes GK; Sawyer AM; Vaca CC; Clerc I; Roh M; Song C; D'Aquila RT
    Transl Res; 2021 Nov; 237():1-15. PubMed ID: 34004371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Patterson AP
    J Biol Chem; 2021 Aug; 297(2):100889. PubMed ID: 34181944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
    Ooms M; Krikoni A; Kress AK; Simon V; Münk C
    J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
    McDonnell MM; Karvonen SC; Gaba A; Flath B; Chelico L; Emerman M
    PLoS Pathog; 2021 Jun; 17(6):e1009523. PubMed ID: 34170969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
    Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
    J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression.
    Jaguva Vasudevan AA; Kreimer U; Schulz WA; Krikoni A; Schumann GG; Häussinger D; Münk C; Goering W
    Front Microbiol; 2018; 9():2088. PubMed ID: 30233553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
    Hou S; Lee JM; Myint W; Matsuo H; Kurt Yilmaz N; Schiffer CA
    J Biol Chem; 2021 Aug; 297(2):100909. PubMed ID: 34171358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.
    Mitra M; Singer D; Mano Y; Hritz J; Nam G; Gorelick RJ; Byeon IJ; Gronenborn AM; Iwatani Y; Levin JG
    Retrovirology; 2015 Jan; 12():3. PubMed ID: 25614027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
    PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
    Abe H; Ochi H; Maekawa T; Hatakeyama T; Tsuge M; Kitamura S; Kimura T; Miki D; Mitsui F; Hiraga N; Imamura M; Fujimoto Y; Takahashi S; Nakamura Y; Kumada H; Chayama K
    Hepatol Res; 2009 Dec; 39(12):1159-68. PubMed ID: 19788695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
    Rose KM; Marin M; Kozak SL; Kabat D
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.
    Wang Y; Schmitt K; Guo K; Santiago ML; Stephens EB
    J Gen Virol; 2016 Jan; 97(1):1-17. PubMed ID: 26489798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytidine deaminase APOBEC3H restricts HIV-1 replication.
    Dang Y; Siew LM; Wang X; Han Y; Lampen R; Zheng YH
    J Biol Chem; 2008 Apr; 283(17):11606-14. PubMed ID: 18299330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
    Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.
    Wang Z; Wakae K; Kitamura K; Aoyama S; Liu G; Koura M; Monjurul AM; Kukimoto I; Muramatsu M
    J Virol; 2014 Jan; 88(2):1308-17. PubMed ID: 24227842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
    Marin M; Golem S; Rose KM; Kozak SL; Kabat D
    J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.